Thrombolytic therapy for acute stroke in the United Kingdom: Experience from the safe implementation of thrombolysis in stroke (SITS) register

QJM: An International Journal of Medicine

Volumn 101, Issue 11, 2008, Pages 863-869

  Lees, K R ^a   Ford, G A ^b   Muir, K W ^c   Ahmed, N ^d   Dyker, A G ^e   Atula, S ^a   Kalra, L ^f   Warburton, E A ^g   Baron, J C ^g   Jenkinson, D F ^h   Wahlgren, N G ^d   Walters, M R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REGISTER; STROKE; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 54949141870     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn102     Document Type: Article

References (29)

1. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-82.
2. The Intercollegiate Working Party for Stroke. National Clinical Guidelines for Stroke. London, Royal College of Physicians London, 2004.
3. Scottish Intercollegiate Guidelines Network. Management of Patients with Stroke Part I: Assessment, Investigation, Immediate Management and Secondary Prevention. Edinburgh, SIGN, 1997.
4. Clinical Effectiveness and Evaluation Unit, Royal College of Physicians of London. National Sentinel Stroke Audit Phase 2. London, Royal College of Physicians, 2007.
5. Moon L, Jacobzone, S. Stroke Care in OECD Countries: A Comparison of Treatment Costs and Outcomes in 17 Countries. Paris, OECD, 2003.
6. House of Commons Committee of Public Accounts. Reducing Brain Damage: Faster Access to Better Stroke Care. London, HMSO, 2006.
7. Walters MR, Muir KW, Harbison J, Lees KR, Ford GA. Intravenous thrombolysis for acute ischaemic stroke: Preliminary experience with recombinant tissue plasminogen activator in the UK. Cerebrovasc Dis 2005; 20:438-42.
8. National Institute for Health and Clinical Excellence. Final Appraisal Determination: Alteplase for the Treatment of Acute Ischaemic Stroke. London, National Institute for Health and Clinical Excellence, 2007.
9. SITS-ISTR. Stockholm, 2007. [www.acutestroke.org (accessed date January 20 2008)].
10. Wahlgren NG, Davalos A, Fieschi C, Grond M, Hacke W, Kaste M, et al The International Stroke Thrombolysis Register for safe implementation of thrombolysis in stroke (SITS). Cerebrovasc Dis 2001; 11(Suppl. 4):79.
11. European Medicines Evaluation Agency committee for human medicinal products. Opinion in Relation to the Revised Conditions for the Safe and Effective use of Actilyse Following an Article 29 Referral. London, EMEA, 2006.
12. The European Cooperative Acute Stroke Study (ECASS). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995; 274:1017-25.
13. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 1998; 652:1245-51.
14. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: Prognosis. Scot Med J 1957; 2:200-15.
15. Lyden PD, Mei L, Levine SR, Brott TG, Broderick J. for the NINDS rtPA Stroke Study Group. A modified National Institutes of Health Stroke Scale for use in stroke clinical trials. Preliminary reliability and validity. Stroke 2001; 32:1310-7.
16. Statistical Office of the European Communities. Europe in Figures: Eurostat Yearbook 2006-2007. Luxembourg, Office for Official Publications of the European Communities, 2007
17. Harraf F, Sharma A, Brown MM. A multicentre observational study of presentation and early assessment of acute stroke. Br Med J 2002; 325:17-21.
18. Barsan W. Time of hospital presentation in patients with acute stroke. Arch Int Med 1993; 153:2258-61.
19. Grond M, Stenzel C, Schmülling S, Rudolf J, Neveling M, Lechleuthner A, et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998; 29:1544-9.
20. Harbison J, Massey A, Barnett L, Hodge D, Ford GA. Rapid ambulance protocol for acute stroke. Lancet 1999; 353:1935.
21. Hacke W, Kulkens S. Thrombolysis with alteplase for acute ischemic stroke: Review of SITS-MOST and other Phase IV studies. Expert Rev Neurother 2007; 7:783-8.
22. Waite K, Silver F, Jaigobin C, Black S, Lee L, Murray B, et al. Telestroke: A multi-site, emergency-based telemedicine service in Ontario. J Telemed Telecare 2006; 12:141-5.
23. Johnston KC, Worrall BB. Teleradiology Assessment of Computerized Tomographs Online Reliability Study. Teleradiology Assessment of Computerized Tomographs Online Reliability Study (TRACTORS) for acute stroke evaluation. Telemed J E-Health 2003; 9:227-33.
24. Weir CJ, Kaste M, Lees KR. Targeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy. Stroke 2004; 35:2111-6.
25. ATLANTIS, ECASS and NINDS Study Group Investigators. Early stroke treatment associated with better outcome: A pooled analysis of ATLANTIS, ECASS and NINDS rt-pa stroke trials. Presented at ASA meeting, San Antonio, February 2002.
26. Clark WM, Albers GW, Madden KP, Hamilton S. for the Thrombolytic Therapy in Acute Ischemic Stroke Study Investigators. The rtPA (Alteplase) 0- to 6-hour acute stroke trial, part A (A-276g). Stroke 2000; 31 811-6.
27. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-7.
28. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, et al. Use of tissue-type plasminogen activator for acuite ishemic stroke. The Cleveland area experience. JAMA 2000; 283:1151-8.
29. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999; 282:2003-11.